Published in J Womens Health (Larchmt) on October 01, 2010
A mixed-methods approach to understanding barriers to postpartum retention in care among low-income, HIV-infected women. AIDS Patient Care STDS (2015) 0.99
Combination antiretroviral treatment for women previously treated only in pregnancy: week 24 results of AIDS clinical trials group protocol a5227. J Acquir Immune Defic Syndr (2014) 0.75
Postpartum Loss to HIV Care and HIV Viral Suppression among Previously Diagnosed HIV-Infected Women with a Live Birth in New York State. PLoS One (2016) 0.75
Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR Recomm Rep (2006) 37.28
Variations in the care of HIV-infected adults in the United States: results from the HIV Cost and Services Utilization Study. JAMA (1999) 10.93
The care of HIV-infected adults in the United States. HIV Cost and Services Utilization Study Consortium. N Engl J Med (1998) 6.26
Hospital and outpatient health services utilization among HIV-infected adults in care 2000-2002. Med Care (2005) 3.19
Loss to follow-up and mortality among pregnant women referred to a community clinic for antiretroviral treatment. AIDS (2008) 2.96
The impact of competing subsistence needs and barriers on access to medical care for persons with human immunodeficiency virus receiving care in the United States. Med Care (1999) 2.85
Adherence to antiretrovirals among US women during and after pregnancy. J Acquir Immune Defic Syndr (2008) 2.38
Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis (2004) 2.17
HIV-infected parents and their children in the United States. Am J Public Health (2000) 2.13
Adherence to antiretroviral treatment among pregnant and postpartum HIV-infected women. AIDS Care (2008) 1.73
Advanced immunosuppression at entry to HIV care in the southeastern United States and associated risk factors. AIDS (2006) 1.30
Pregnant women with HIV infection can expect healthy survival: three-year follow-up. J Acquir Immune Defic Syndr (2006) 0.99
Acquired immunodeficiency syndrome in Alabama: special concerns for black women. South Med J (1997) 0.93
Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study. Pediatrics (2008) 0.87
Screening for human immunodeficiency virus infection during pregnancy. Pediatr AIDS HIV Infect (1997) 0.80
Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: evidence-based recommendations from an International Association of Physicians in AIDS Care panel. Ann Intern Med (2012) 7.04
Lessons learned from use of highly active antiretroviral therapy in Africa. Clin Infect Dis (2005) 4.96
Incidence and prevalence of hepatitis C in prisons and other closed settings: results of a systematic review and meta-analysis. Hepatology (2013) 3.54
Human immunodeficiency virus in correctional facilities: a review. Clin Infect Dis (2002) 3.27
Feasibility and acceptability of rapid HIV testing in jail. AIDS Patient Care STDS (2007) 2.52
It is time to implement routine, not risk-based, HIV testing. Clin Infect Dis (2005) 2.40
Natural history of human immunodeficiency virus disease in southern India. Clin Infect Dis (2002) 2.39
Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India. J Acquir Immune Defic Syndr (2006) 2.30
Survey finds that many prisons and jails have room to improve HIV testing and coordination of postrelease treatment. Health Aff (Millwood) (2014) 2.21
HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study. J Acquir Immune Defic Syndr (2011) 1.97
Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India. J Acquir Immune Defic Syndr (2004) 1.97
The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India. Clin Infect Dis (2005) 1.95
The importance of routine HIV testing in the incarcerated population: the Rhode Island experience. AIDS Educ Prev (2002) 1.91
A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users. AIDS (2007) 1.83
Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge. J Health Care Poor Underserved (2008) 1.81
Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle. J Immunol (2002) 1.76
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries. J Acquir Immune Defic Syndr (2002) 1.71
Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world. AIDS (2011) 1.63
Adverse effects of highly active antiretroviral therapy in developing countries. Clin Infect Dis (2007) 1.56
Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention. J Acquir Immune Defic Syndr (2010) 1.47
The use of community-based modified directly observed therapy for the treatment of HIV-infected persons. J Acquir Immune Defic Syndr (2005) 1.46
Decrease in the proportion of injecting drug use-related HIV/AIDS in Massachusetts, New York, Connecticut, and Rhode Island. AIDS Read (2008) 1.42
Clinical profile of HIV in India. Indian J Med Res (2005) 1.41
A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy. AIDS Read (2005) 1.38
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy. AIDS (2007) 1.34
Adherence to HIV treatment and care among previously homeless jail detainees. AIDS Behav (2013) 1.33
Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care (2011) 1.31
Apathy is associated with volume of the nucleus accumbens in patients infected with HIV. J Neuropsychiatry Clin Neurosci (2005) 1.29
The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India. AIDS (2003) 1.27
A success story: HIV prevention for injection drug users in Rhode Island. Subst Abuse Treat Prev Policy (2006) 1.26
Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration. Sex Transm Dis (2006) 1.26
Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients. AIDS Patient Care STDS (2008) 1.26
HIV-related research in correctional populations: now is the time. Curr HIV/AIDS Rep (2011) 1.25
The impact of apathy and depression on quality of life in patients infected with HIV. AIDS Patient Care STDS (2003) 1.24
Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus. J Neuropsychiatry Clin Neurosci (2005) 1.18
Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings. J Acquir Immune Defic Syndr (2004) 1.13
Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative. J Acquir Immune Defic Syndr (2011) 1.10
Acceptance of HIV testing among African-American college students at a historically black university in the south. J Natl Med Assoc (2006) 1.08
HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care. Curr Opin Infect Dis (2013) 1.07
A review of the case for hepatitis B vaccination of high-risk adults. Am J Med (2003) 1.06
Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment. Sex Transm Dis (2002) 1.04
Initial outcomes of an emergency department rapid HIV testing program in western Kenya. AIDS Patient Care STDS (2007) 1.03
The impact of removing the immigration ban on HIV-infected persons. AIDS Patient Care STDS (2011) 1.02
Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav (2013) 1.02
Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine. J Acquir Immune Defic Syndr (2011) 1.02
Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings. Am J Public Health (2014) 0.99
Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1. Clin Infect Dis (2002) 0.97
Young incarcerated men's perceptions of and experiences with HIV testing. Am J Public Health (2007) 0.97
Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients. AIDS (2005) 0.95
HIV-positive and in jail: race, risk factors, and prior access to care. AIDS Behav (2013) 0.95
Linkage to care for HIV-infected heterosexual men in the United States. Clin Infect Dis (2011) 0.95
Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions. J Int AIDS Soc (2010) 0.95
Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care. J Acquir Immune Defic Syndr (2011) 0.94
Short communication: Transmitted drug resistance and molecular epidemiology in antiretroviral naive HIV type 1-infected patients in Rhode Island. AIDS Res Hum Retroviruses (2010) 0.92
Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens. HIV Clin Trials (2003) 0.91
Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India. PLoS One (2013) 0.91
Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav (2013) 0.91
Information and Communication Technology to Link Criminal Justice Reentrants to HIV Care in the Community. AIDS Res Treat (2013) 0.89
Routine HIV testing among inpatients. Arch Intern Med (2002) 0.89
HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients. AIDS (2002) 0.89
HIV risk behavior before and after HIV counseling and testing in jail: a pilot study. J Acquir Immune Defic Syndr (2010) 0.88
Impact of immigration on the molecular epidemiology of tuberculosis in Rhode Island. J Clin Microbiol (2010) 0.88
Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2005) 0.87
Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients. J Int Assoc Physicians AIDS Care (Chic) (2011) 0.85
Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India. PLoS One (2010) 0.84
Short communication: new HIV infections at Southern New England academic institutions: implications for prevention. AIDS Res Hum Retroviruses (2012) 0.84
Caring for HIV-infected refugees in Rhode Island. Med Health R I (2007) 0.83
The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action. J Infect Dis (2011) 0.83
Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007. Med Health R I (2009) 0.83
Racial/ethnic attitudes towards HIV testing in the primary care setting. J Natl Med Assoc (2005) 0.82
Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen. Clin Infect Dis (2011) 0.81
Evaluation of longitudinal clinical outcomes and adherence to care among HIV-infected refugees. J Int Assoc Provid AIDS Care (2012) 0.81
Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy? J Addict Med (2012) 0.81
Monitoring HIV treatment in the developing world. Lancet Infect Dis (2002) 0.80
Patient and clinician ethical perspectives on the 2006 Centers for Disease Control and prevention HIV testing methods. Public Health Rep (2012) 0.80
HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City. AIDS Res Treat (2011) 0.80
Community-based interventions for marginalized populations. Clin Infect Dis (2004) 0.80
HIV among marginalized populations in Rhode Island. Med Health R I (2009) 0.79
Directly observed therapy (DOT) for individuals with HIV: successes and challenges. MedGenMed (2003) 0.79
Small reservoirs: jail screening for gonorrhea and Chlamydia in low prevalence areas. J Correct Health Care (2009) 0.79
The implementation of the CDC's revised recommendations for HIV testing in medical settings: a Rhode Island update and call for action. Med Health R I (2009) 0.78
Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men. Clin Infect Dis (2008) 0.78
Development of opportunistic infections after diagnosis of active tuberculosis in HIV-infected patients. AIDS Patient Care STDS (2004) 0.78
Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence. AIDS (2003) 0.78
Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India. J Int Assoc Provid AIDS Care (2012) 0.78
Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye? Clin Infect Dis (2013) 0.77
The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult. Clin Infect Dis (2006) 0.77
Editorial comment: correctional opportunities to address the HIV/AIDS epidemic. AIDS Read (2006) 0.76
Directly observed therapy for HIV/tuberculosis co-infection. Lancet Infect Dis (2004) 0.76
Routine HIV testing in US prisons. Lancet Infect Dis (2007) 0.76
Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir. AIDS (2006) 0.75